| When does 2 plus 2 equal 5? A review of antimicrobial synergy testing CD Doern Journal of clinical microbiology 52 (12), 4124-4128, 2014 | 408 | 2014 |
| It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations CD Doern, BD Carey-Ann Journal of clinical microbiology 48 (11), 3829-3835, 2010 | 235 | 2010 |
| Point-Counterpoint: β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections ES Theel, CD Doern Journal of clinical microbiology 51 (11), 3478-3483, 2013 | 209 | 2013 |
| Macrolide-Resistant Streptococcus pyogenes in the United States, 2002–2003 SS Richter, KP Heilmann, SE Beekmann, NJ Miller, AL Miller, CL Rice, ... Clinical infectious diseases 41 (5), 599-608, 2005 | 196 | 2005 |
| Diagnosis of urinary tract infections in children CD Doern, SE Richardson Journal of clinical microbiology 54 (9), 2233-2242, 2016 | 121 | 2016 |
| Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB) CD Doern, AL Roberts, W Hong, J Nelson, S Lukomski, WE Swords, ... Microbiology 155 (1), 46-52, 2009 | 97 | 2009 |
| Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp.(C. jejuni and C. coli), and … SM Harrington, BW Buchan, C Doern, R Fader, MJ Ferraro, DR Pillai, ... Journal of clinical microbiology 53 (5), 1639-1647, 2015 | 91 | 2015 |
| Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients SG Beal, J Ciurca, G Smith, J John, F Lee, CD Doern, RM Gander Journal of clinical microbiology 51 (12), 3988-3992, 2013 | 91 | 2013 |
| Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA JY Park, KB Dunbar, M Mitui, CA Arnold, DM Lam-Himlin, MA Valasek, ... Digestive diseases and sciences 61, 2373-2380, 2016 | 88 | 2016 |
| Neonatal adenoviral infection: a seventeen year experience and review of the literature A Ronchi, C Doern, E Brock, L Pugni, PJ Sánchez The Journal of pediatrics 164 (3), 529-535. e4, 2014 | 69 | 2014 |
| Emerging and future applications of matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in the clinical microbiology laboratory: a report … CD Doern, SM Butler-Wu The Journal of Molecular Diagnostics 18 (6), 789-802, 2016 | 67 | 2016 |
| The clinical usefulness of polymerase chain reaction as a supplemental diagnostic tool in the evaluation and the treatment of children with septic arthritis K Carter, C Doern, CH Jo, LAB Copley Journal of Pediatric Orthopaedics 36 (2), 167-172, 2016 | 65 | 2016 |
| Alternative doffing strategies of personal protective equipment to prevent self-contamination in the health care setting K Osei-Bonsu, N Masroor, K Cooper, C Doern, KK Jefferson, Y Major, ... American journal of infection control 47 (5), 534-539, 2019 | 64 | 2019 |
| Brain magnetic resonance imaging of infants with bacterial meningitis CR Oliveira, MC Morriss, JG Mistrot, JB Cantey, CD Doern, PJ Sánchez The Journal of pediatrics 165 (1), 134-139, 2014 | 63 | 2014 |
| Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter … KV Sullivan, NN Turner, SS Roundtree, S Young, CA Brock-Haag, ... Journal of clinical microbiology 51 (11), 3579-3584, 2013 | 61 | 2013 |
| Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion … CD Doern, WM Dunne Jr, CAD Burnham Journal of clinical microbiology 49 (3), 1143-1147, 2011 | 59 | 2011 |
| Loss of the Group A Streptococcus Regulator Srv Decreases Biofilm Formation In Vivo in an Otitis Media Model of Infection AL Roberts, KL Connolly, CD Doern, RC Holder, SD Reid Infection and immunity 78 (11), 4800-4808, 2010 | 59 | 2010 |
| GRP78/Dna K is a target for Nexavar/Stivarga/Votrient in the treatment of human malignancies, viral infections and bacterial diseases JL Roberts, M Tavallai, A Nourbakhsh, A Fidanza, T Cruz‐Luna, E Smith, ... Journal of cellular physiology 230 (10), 2552-2578, 2015 | 58 | 2015 |
| Multicenter study demonstrates standardization requirements for mold identification by MALDI-TOF MS AF Lau, RC Walchak, HB Miller, ES Slechta, K Kamboj, K Riebe, ... Frontiers in microbiology 10, 2098, 2019 | 53 | 2019 |
| The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureusbacteremia H Honda, CD Doern, W Michael-Dunne, DK Warren BMC infectious diseases 11, 1-8, 2011 | 49 | 2011 |
Carey-Ann BurnhamProfessor of Pathology & Immunology在 path.wustl.edu 的电子邮件经过验证
